{
    "title": "French biotech firm closes in on cancer that killed Steve Jobs",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4320892/French-biotech-firm-closes-cancer-killed-Steve-Jobs.html",
    "date": "2017-03-16",
    "keywords": [
        "drug",
        "europe",
        "approval",
        "cancer",
        "lutathera",
        "medicine",
        "buono",
        "radiotherapy",
        "disease",
        "particle",
        "fda",
        "end",
        "use",
        "science",
        "ben",
        "biotech",
        "firm",
        "type",
        "accelerator",
        "research",
        "centre",
        "nasdaqit",
        "mln",
        "quarter",
        "executive",
        "stefano",
        "thursday",
        "dollar",
        "interview",
        "visit",
        "momentlutathera",
        "molecule",
        "energy",
        "injection",
        "proteinit",
        "survival",
        "apple",
        "cofounder",
        "road",
        "drugmaker",
        "headquarters",
        "border",
        "hadron",
        "collider",
        "smasher",
        "filing",
        "food",
        "administration",
        "timetable",
        "potential",
        "launch",
        "verdict",
        "agency",
        "summer",
        "resubmission",
        "quarterin",
        "phase",
        "trial",
        "journal",
        "risk",
        "progression",
        "care",
        "novartis",
        "afinitor",
        "compassionate",
        "programme",
        "france",
        "authorisation",
        "price",
        "course",
        "injectionsaaa",
        "startup",
        "imagingbut",
        "appreciation",
        "decision",
        "nasdaq",
        "billionwe",
        "money",
        "effort",
        "fenton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}